Latest filing published 25 Oct 2013 for Angiodynamics INC.
No signal scores available.
Based on 15 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Vincent Bucci discloses dealings in 2 companies, chiefly Angiodynamics Inc and Rita Medical Systems Inc. Between 3 July 2006 and 23 October 2013, the trades on record add up to 22 filings.
The open-market record is one-sided, with 15 purchases worth €957k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants and 1 option exercise. 2013 to date brings 5 purchases and no sales.
A typical purchase (the median) is worth €20k. After 15 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -0.8%. This is a record of the past, not a forecast.
The latest filing, published on 25 October 2013, reports a share grant in Angiodynamics Inc. The last purchase on record was published on 21 October 2013, which is 4,750 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations